Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor

Journal of Pharmacology and Experimental Therapeutics

Volumn 305, Issue 3, 2003, Pages 1104-1115

  Seifert, Roland ^a   Wenzel Seifert, Katharina ^a   Bürckstümmer, Tilmann ^a,b   Pertz, Heinz H ^b   Schunack, Walter ^b   Dove, Stefan ^c   Buschauer, Armin ^c   Elz, Sigurd ^c  

^a UNIVERSITY OF KANSAS   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 FLUOROPHENYL)HISTAMINE; 2 (2 THIAZOLYL)ETHYLAMINE; 2 (3 FLUOROPHENYL)HISTAMINE; 2 (3 METHYLPHENYL)HISTAMINE; 2 BENZYLHISTAMINE; 2 METHYLHISTAMINE; 2 PHENYLHISTAMINE; 2 PHENYLHISTAMINE DERIVATIVE; ARPROMIDINE; BETAHISTINE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; HISTAMINE; HISTAMINE DERIVATIVE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR AGONIST; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; HISTAPRODIFEN DERIVATIVE; ISOLEUCINE; ISOPROTEIN; LEUCINE; MEPYRAMINE; MUTANT PROTEIN; PHENYLALANINE; RGS PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALINE;

AGONIST; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVITY; GENE EXPRESSION; GUINEA PIG; HUMAN; INSECT CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; ELECTROPHORESIS; GTP PHOSPHOHYDROLASES; GUINEA PIGS; HISTAMINE; HISTAMINE AGONISTS; HISTAMINE ANTAGONISTS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PYRILAMINE; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2; RECOMBINANT PROTEINS; SPECIES SPECIFICITY; TRITIUM;

EID: 0037799814     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.049619     Document Type: Article

References (39)

1. q-11-subunits in constitutive and agonist-mediated signaling. Mol Pharmacol 60:1133-1142.
2. Ballesteros JA, Shi L, and Javitch JA (2001) Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol Pharmacol 60:1-19.
3. Buschauer A (1989) Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs. J Med Chem 32:1963-1970.
4. 3H]mepyramine binding of brain membranes. J Neurochem 32:1653-1663.
5. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
6. 1-receptor agonists. J Med Chem 43:1071-1084.
7. 1 receptor gene. Biochem Biophys Res Commun 201:894-901.
8. 2 receptors expressed in Sf9 and COS7 cells. FEBS Lett 409:283-286.
9. 2S receptor in baculovirus-infected insect cells. Biochemistry 35:15149-15161.
10. Hebert TE and Bouvier M (1998) Structural and functional aspects of G protein-coupled receptor oligomerization. Biochem Cell Biol 76:1-11.
11. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, and Haas HL (1997) International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49:253-278.
12. Hough LB (2001) Genomics meets histamine receptors: new subtypes, new receptors. Mol Pharmacol 59:415-419.
13. q-protein coupling. J Neurochem 80:678-696.
14. Hoyer D and Boddeke HW (1993) Partial agonists, full agonists, antagonists: dilemmas of definition. Trends Pharmacol Sci 14:270-275.
15. 2-receptor with guanidine-type agonists. Mol Pharmacol 60:1210-1225.
16. Kenakin T (1996) The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol Rev 48:413-463.
17. 1 receptor agonist activity of a series of 2-phenylhistamines, 2-heteroarylhistamines and analogues. J Med Chem 38:1287-1294.
18. 1 agonists. Biochem Biophys Res Commun 214:110-117.
19. 1-receptor agonists. Biochem Biophys Res Commun 201:295-301.
20. 3 receptors: role of two amino acids in the third transmembrane domain. Br J Pharmacol 131:1247-1250.
21. 4 receptors reveals substantial pharmacological species variation. J Pharmacol Exp Ther 299:121-130.
22. 3 receptor reveals distinct species pharmacological profiles. J Pharmacol Exp Ther 293:771-778.
23. 1 receptors during smooth muscle cell differentiation. Mol Pharmacol 35:311-318.
24. 1 receptor. Eur J Pharmacol 345:111-117.
25. 194. Biochem Biophys Res Commun 203:1096-1101.
26. s. J Pharmacol Exp Ther 294:407-412.
27. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, et al. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science (Wash DC) 289:739-745.
28. 2-selective muscarinic receptor antagonist. Eur J Pharmacol 286:229-240.
29. 1-receptor: comparison of several brain regions and animal species. J Neurochem 53:335-339.
30. i proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes. Mol Pharmacol 45:578-586.
31. sα fusion protein. Eur J Biochem 255:369-382.
32. i-protein coupling in two formyl peptide receptor mutants associated with localized juvenile periodontitis. J Biol Chem 276:42043-42049.
33. Seifert R and Wenzel-Seifert K (2002) Constitutive activity of G-protein-coupled receptors: Cause of disease and common property of wild-type receptors. Naunyn-Schmiedeberg's Arch Pharmacol 366:381-416.
34. 1 receptor. I. Gene cloning, characterization and tissue expression revealed by in situ hybridization. J Neurochem 62:507-518.
35. 2A receptor inverse agonists as antipsychotics. J Pharmacol Exp Ther 299:268-276.
36. q-proteins. Mol Pharmacol 58:954-966.
37. 1 receptor. J Biol Chem 274:29994-30000.
38. 1-agonistic activity. Eur J Med Chem 25:673-680.
39. 1-receptor agonists. Prog Drug Res 44:49-85.